Dan Stevens
Chief Medical Officer Blue Earth Therapeutics Ltd.
Dan is a board certified (UK) pharmaceutical physician with a dedication to translational science and drug development. His industry career is underpinned by NHS clinical academic training and he is a Fellow of the Faculty of Pharmaceutical Medicine at the Royal College of Physicians. His experience in industry has been focused on novel oncology drug development from lead identification through to NDA. His expertise lies in clinical development and medical affairs as they relate to oncology and urology. Most recently, he has developed specific experience in targeted radioligand therapy. Leading, or being part of, development teams which have taken 4 novel molecules into the clinic in the US and Europe, successfully navigating manufacturing, operational and regulatory challenges.
Seminars
- Clarifying the unique regulatory requirements for radiopharmaceuticals versus conventional therapies like ADCs
- Aligning early-phase trial designs with risk-based, patient-centric approaches to accelerate first-in-human studies
- Facilitating global harmonization by comparing regulatory frameworks in the US, Europe, China, and Australia to reduce development delays
